Sitemap
Page 1 of 3 : Next
Posts
- Category: Acne
- Category: Cancer
- Angiosarcoma of the of Scalp with Calvarium
- Angiosarcoma of the of Scalp with Calvarium: CASE REPORT
- Angiosarcoma of the of Scalp with Calvarium: DISCUSSION
- Colorectal, Breast, and Prostate Cancers in Medicaid
- Colorectal, Breast, and Prostate Cancers in Medicaid: DISCUSSION
- Colorectal, Breast, and Prostate Cancers in Medicaid: DISCUSSION part 2
- Colorectal, Breast, and Prostate Cancers in Medicaid: METHODS
- Colorectal, Breast, and Prostate Cancers in Medicaid: RESULTS
- Mammography Use
- Mammography Use: DISCUSSION
- Mammography Use: METHODS
- Mammography Use: RESULTS
- Mammography Use: STATISTICAL ANALYSIS Major
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: HORMONE REPLACEMENT THERAPY
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: The PEPI Trial
- Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease: The WHI Trial
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: INTENSITY-MODULATED RADIATION THERAPY
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: STEREOTACTIC RADIOSURGERY
- RADIATION MEDICINE INNOVATIONS FOR THE NEW MILLENIUM: ULTRASOUND-GUIDED TRANSPERINEAL
- Category: Diabetes
- Adherence to Canadian Diabetes Association Clinical Practice Guidelines
- Adherence to Canadian Diabetes Association Clinical Practice Guidelines: DISCUSSION
- Adherence to Canadian Diabetes Association Clinical Practice Guidelines: DISCUSSION part 2
- Adherence to Canadian Diabetes Association Clinical Practice Guidelines: METHODS
- Adherence to Canadian Diabetes Association Clinical Practice Guidelines: RESULTS
- APPLICATION OF BODY MASS INDEX PRINCIPLES
- APPLICATION OF BODY MASS INDEX PRINCIPLES: DISCUSSION
- APPLICATION OF BODY MASS INDEX PRINCIPLES: METHODS
- APPLICATION OF BODY MASS INDEX PRINCIPLES: RESULTS
- Pfizer Diabetes
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus: CRP and Metabolic Dysfunction
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus: CRP and Metabolic Dysfunction in Nonwhite Populations
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus: Metabolic Syndrome, CRP and Cardiovascular Events
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus: Statin Therapy for Elevated CRP
- Relationship of C-Reactive Protein, Metabolic Syndrome and Diabetes Mellitus: Thiazolidinediones
- Rimonabant (Acomplia)
- Rimonabant (Acomplia): CHEMICAL AND PHYSICAL PROPERTIES/MECHANISM OF ACTION
- Rimonabant (Acomplia): DOSAGE
- Rimonabant (Acomplia): EFFICACY IN CLINICAL TRIALS
- Statins and Diabetes Mellitus
- Statins and Diabetes Mellitus: part 2
- TYPE 2 DIABETES MELLITUS, HYPERTENSION AND CONCURRENT TYPE 2 DIABETES, AND HYPERTENSION
- TYPE 2 DIABETES MELLITUS, HYPERTENSION AND CONCURRENT TYPE 2 DIABETES, AND HYPERTENSION: DISCUSSION
- TYPE 2 DIABETES MELLITUS, HYPERTENSION AND CONCURRENT TYPE 2 DIABETES, AND HYPERTENSION: PATIENTS AND METHODS
- TYPE 2 DIABETES MELLITUS, HYPERTENSION AND CONCURRENT TYPE 2 DIABETES, AND HYPERTENSION: RESULTS
- Category: Disease
- A Case of a Surviving Male Infant with Incontinentia Pigmenti
- A Case of a Surviving Male Infant with Incontinentia Pigmenti: CASE REPORT
- A Case of a Surviving Male Infant with Incontinentia Pigmenti: DISCUSSION
- A Case of ClearCeU Sarcoma Occurring on the Abdomen
- A Case of ClearCeU Sarcoma Occurring on the Abdomen: CASE REPORT
- A Case of ClearCeU Sarcoma Occurring on the Abdomen: DISCUSSION
- A Case of ClearCeU Sarcoma Occurring on the Abdomen: DISCUSSION part 2
- A Case of Dermatitis Neglecta
- A Case of Dermatitis Neglecta: CASE REPORT
- A Case of Dermatitis Neglecta: DISCUSSION
- A Case of Unilateral Motor Paralysis
- A Case of Unilateral Motor Paralysis: CASE REPORT
- A Case of Unilateral Motor Paralysis: DISCUSSION
- A clinical case of familial Paget's disease of bone complicated by early osteogenic sarcoma
- A clinical case of familial Paget's disease of bone complicated by early osteogenic sarcoma: Discussion
- A Comparison of Services Provided by Pharmacists and Nurses
- A Comparison of Services Provided by Pharmacists and Nurses: DISCUSSION
- A Comparison of Services Provided by Pharmacists and Nurses: METHODS
- A Comparison of Services Provided by Pharmacists and Nurses: RESULTS
- A familial case of Paget's disease of bone with mutation at exon 8 of the sequestosome gene
- A familial case of Paget's disease of bone with mutation at exon 8 of the sequestosome gene: Materials and methods
- A familial case of Paget's disease of bone with mutation at exon 8 of the sequestosome gene: Results
- A familial case of Paget's disease of bone with mutation at exon 8 of the sequestosome gene: Treatment
- Achalasia: Dilation, injection or surgery?
- Achalasia: Dilation, injection or surgery? EFFECT OF PREVIOUS TREATMENT
- Achalasia: Dilation, injection or surgery? INJECTION
- Achalasia: Dilation, injection or surgery? PRINCIPLES OF THERAPY
- Anomalous Inferior Vena Cava with Azygos Continuation, Dysgenesis of Lung
- Anomalous Inferior Vena Cava with Azygos Continuation, Dysgenesis of Lung: Case report continue
- Anomalous Inferior Vena Cava with Azygos Continuation, Dysgenesis of Lung: DISCUSSION
- Bilateral Pleural-Based Densities in a Patient with Hip Pain
- Bilateral Pleural-Based Densities in a Patient with Hip Pain: Diagnosis
- Citrates in nephrolithiasis
- Citrates in nephrolithiasis: Citrate salts in the treatment of nephrolithiasis
- Citrates in nephrolithiasis: Citrate salts in the treatment of nephrolithiasis part 2
- Citrates in nephrolithiasis: Hypocitraturia
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease: CASE REPORTS
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease: DISCUSSION
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease: DISCUSSION part 2
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease: MATERIALS AND METHODS
- Cricopharyngeal Dysfunction in Chronic Obstructive Pulmonary Disease: RESULTS
- Digestive Disease Week
- Digestive Disease Week: part 2
- Establishing a Cohort to Investigate Health Disparities
- Establishing a Cohort to Investigate Health Disparities: DISCUSSION
- Establishing a Cohort to Investigate Health Disparities: MATERIALS AND METHODS
- Establishing a Cohort to Investigate Health Disparities: RESULTS
- Infliximab Therapy for Crohn's Disease
- Interstitial Pulmonary Disease Induced by Occupational Exposure to Paraffin
- Interstitial Pulmonary Disease Induced by Occupational Exposure to Paraffin: DISCUSSION
- New Diagnostic Modalities in the Diagnosis of Heart Failure
- New Diagnostic Modalities in the Diagnosis of Heart Failure: part 2
- New Diagnostic Modalities in the Diagnosis of Heart Failure: part 3
- New Diagnostic Modalities in the Diagnosis of Heart Failure: part 4
- Paget's disease of the hip
- Paget's disease of the hip: Treatment
- Papular Elastorrhexis
- Papular Elastorrhexis: CASE REPORT
- Papular Elastorrhexis: DISCUSSION
- Prevalence of Parkinson's Disease
- Prevalence of Parkinson's Disease: Africa
- Prevalence of Parkinson's Disease: DEATH CERTIFICATES
- Prevalence of Parkinson's Disease: SUMMARY AND CONCLUSIONS
- Putting ALLHAT into Perspective
- Putting ALLHAT into Perspective: WILL ALLHAT CHANGE THE TREATMENT OF HYPERTENSION?
- Silent ischemia a clinical update
- Silent ischemia a clinical update: ANSWERS
- Silent ischemia a clinical update: ANSWERS part 2
- Silent ischemia a clinical update: ANSWERS part 3
- Silent ischemia a clinical update: CASE 2
- Skin Metastasis of Neuroendocrine Carcinoma Arising
- Skin Metastasis of Neuroendocrine Carcinoma Arising: Case report
- Skin Metastasis of Neuroendocrine Carcinoma Arising: DISCUSSION
- SSRI ANTIDEPRESSANT WITHDRAWAL SYNDROME
- SSRI ANTIDEPRESSANT WITHDRAWAL SYNDROME: part 2
- Use of community resources before inflammatory bowel disease surgery
- Use of community resources before inflammatory bowel disease surgery: DISCUSSION
- Use of community resources before inflammatory bowel disease surgery: RESULTS
- Use of community resources before inflammatory bowel disease surgery: SUBJECTS AND METHODS
- Category: Drugs
- Abuse of Stimulant Medications
- Evaluation of 2 Weight-Based Protocols
- Evaluation of 2 Weight-Based Protocols: DISCUSSION
- Evaluation of 2 Weight-Based Protocols: METHODS
- Evaluation of 2 Weight-Based Protocols: RESULTS
- Evaluation of 2 Weight-Based Protocols: RESULTS part 2
- Inventory of Drug Samples in a Health Care Institution
- Inventory of Drug Samples in a Health Care Institution: DISCUSSION
- Inventory of Drug Samples in a Health Care Institution: DISCUSSION part 2
- Inventory of Drug Samples in a Health Care Institution: DISCUSSION part 3
- Inventory of Drug Samples in a Health Care Institution: INTRODUCTION part 2
- Inventory of Drug Samples in a Health Care Institution: METHODS
- Inventory of Drug Samples in a Health Care Institution: RESULTS
- Medicare Drug Bill Passes
- Pentoxifylline Improves Pulmonary Gas Exchange
- Pentoxifylline Improves Pulmonary Gas Exchange: DISCUSSION
- Pentoxifylline Improves Pulmonary Gas Exchange: DISCUSSION part 2
- Pentoxifylline Improves Pulmonary Gas Exchange: METHODS
- Pentoxifylline Improves Pulmonary Gas Exchange: METHODS part 2
- Pentoxifylline Improves Pulmonary Gas Exchange: RESULTS
- Pentoxifylline Improves Pulmonary Gas Exchange: RESULTS part 2
- Pharmaceutical Approval Update
- Pharmaceutical Approval Update: Arformoterol Tartrate Inhalation Solution (Brovana)
- Pharmaceutical Approval Update: Travoprost Z Ophthalmic Sterile Solution 0.004% (Travatan Z)
- Pharmaceutical-Approval Update
- Pharmaceutical-Approval Update: Alefacept (Amevive®)
- Pharmaceutical-Approval Update: Cyclosporine Ophthalmic Emulsion, 0.05% (Restasis™)
- Prospective Randomized Trial of Patient-Controlled Analgesia
- Prospective Randomized Trial of Patient-Controlled Analgesia: DISCUSSION
- Prospective Randomized Trial of Patient-Controlled Analgesia: PATIENTS AND METHODS
- Prospective Randomized Trial of Patient-Controlled Analgesia: PATIENTS AND METHODS part 2
- Prospective Randomized Trial of Patient-Controlled Analgesia: RESULTS
- Putting ALLHAT into Perspective: DO DRUG COMPANIES CREATE PROBLEMS OR FIND SOLUTIONS?
- Putting ALLHAT into Perspective: WHY CAN'T EVERYONE JUST TAKE A DIURETIC?
- Quality and Usability of Common Drug Information Databases
- Quality and Usability of Common Drug Information Databases: DISCUSSION
- Quality and Usability of Common Drug Information Databases: METHODS
- Quality and Usability of Common Drug Information Databases: METHODS part 2
- Quality and Usability of Common Drug Information Databases: RESULTS
- Ramelteon (Rozerem)
- Ramelteon (Rozerem): ADVERSE DRUG EFFECTS
- Ramelteon (Rozerem): CHEMICAL AND PHYSICAL PROPERTIES
- Ramelteon (Rozerem): DOSAGE
- Ramelteon (Rozerem): Roth et al.
- Second-Generation Antipsychotic Agents
- Stability of Ketamine-Propofol Mixtures for Procedural Sedation
- Stability of Ketamine-Propofol Mixtures for Procedural Sedation: DISCUSSION
- Stability of Ketamine-Propofol Mixtures for Procedural Sedation: METHODS
- Stability of Ketamine-Propofol Mixtures for Procedural Sedation: RESULTS
- Stability of Vancomycin 25 mg/mL in Ora-Sweet
- Stability of Vancomycin 25 mg/mL in Ora-Sweet: DISCUSSION
- Stability of Vancomycin 25 mg/mL in Ora-Sweet: METHODS
- Stability of Vancomycin 25 mg/mL in Ora-Sweet: METHODS part 2
- Stability of Vancomycin 25 mg/mL in Ora-Sweet: RESULTS
- Subsequent Prescribing of New Drugs
- Subsequent Prescribing of New Drugs: DISCUSSION
- Subsequent Prescribing of New Drugs: Drug Variables
- Subsequent Prescribing of New Drugs: METHODS
- Subsequent Prescribing of New Drugs: RESULTS
- Suggestions for Resolving Conflicts in Drug Therapy
- The National Medicare Prescription Drug Congress
- The National Medicare Prescription Drug Congress: The CMS Perspective
- The National Medicare Prescription Drug Congress: The Drug Manufacturers' Perspective
Plugin by dagondesign.com